intra-articular injection of hyaluronic acid in sterile syringe (16mg in 2ml)
Cartilage protection, antiinflammatory and analgesic action, structural anabolic action in the treatment of patients with symptomatic knee OA
QuattroTi DenTech has been working in the dental field for 35 years and is proud of having created unique, exclusive intra-oral devices, made from a special thermoplastic material, used by specialists to prevent, protect and cure
SIFI was established in Catania in 1935. Retaining its exclusive focus on Eye Care, the company has grown over time, extending its business activities beyond pharmaceuticals, to also embrace surgery and diagnostics.
Montefarmaco OTC ranks among the Italian leading over-the-counter (OTC) manufacturers. It provides a wide range of pharmaceutical products that enhance your well-being: self-medication drugs, dietary products, para pharmaceuticals, medical devices and cosmetics.
ZambonCelebrating one hundred years of timeless values ( 1906 - 2006 ), Zambon is a leading pharmaceutical and chemical multinational with a reputation for inventive and innovative thinking, flexibility and customer focus.
The technologies of interest are those showing the potential to generate innovative products bringing real benefits to patients in the therapeutic areas relevant for the parent company
The Nasaleze story all began one day in 1990...
Mike James was working in a factory making cosmetic facemasks using a number of ingredients. Mike noticed that despite there usually being clouds of white powder in the air nobody ever sneezed.
At the same time his teenage son was suffering terribly from allergies, sneezing almost constantly. Mike’s mind was cast back to the clouds of white powder in the factory. The following day he brought home some of this (cellulose) powder and suggested his sneezing son should ‘sniff’ some of the powder off the back of his hand.
The sneezing stopped in a matter of seconds and all the other symptoms subsided over the next few minutes.
Mike immediately set about researching and developing his idea, including creating the unique and patented special delivery system. After the initial research proved encouraging Mike was ready to bring his invention to market.
The Medicines Control Agency looked into the issue in greater detail and came to the conclusion that Nasaleze was in fact a low risk product, not a drug and that it should be registered as a Class 1 Medical Device under EU Directive 93/42/EEC.
Nasaleze is now distributed in over 30 countries worldwide and is gaining respect from the Medical Community after successive and successful clinical studies.
Lisoma International Ltd has the international rights to Herstat (3% propolis ACF ointment) for the treatment of the symptoms of herpes simplex lesions, or cold sores.
The company was established in the UK in 1999 (originally as Hela International Ltd), to deal with regulatory, licensing and marketing issues and to appoint distributors for Herstat products, worldwide.